The delta2-opioid receptor subtype stimulates phosphoinositide metabolism in mouse periaqueductal gray matter.
The delta(delta)-opioid agonists [D-Pen2,5]enkephalin (DPDPE) and [D-Ala2]deltorphin II increased the formation of inositol phosphates (IPs) in mice periaqueductal gray matter (PAG) slices pre-labeled with myo-[3H]inositol. Both delta-agonists caused an increase in IP accumulation in a dose-dependent manner (1-100 microM) and which was pertussis toxin (0.5 microg/mouse, i.c.v.) sensitive. This effect was blocked by the delta-antagonist ICI-174.864 (10 microM). The presence of subtypes of the delta-opioid receptor (delta1 and delta2) in PAG has been suggested by pharmacological studies. In this brain structure, naltrindrole 5'-isothiocyanate (5'-NTII), but not 7-benzylidenenaltrexone (BNTX), antagonized the effects of DPDPE and [D-Ala2]deltorphin II, suggesting the involvement of a population of delta receptors sensitive to the delta2-antagonist NT II on this effect. To further investigate the participation of delta-receptor subtypes in the stimulation of IPs formation, mice were injected with antisense oligodeoxynucleotides (ODNs) directed to nucleotides 7-26 or 2946 of the cloned delta-receptor mRNA, and PAG slices from these animals were used in in vitro assays. The results demonstrate that the reported increase of phosphoinositide (PI) hydrolysis depends on the agonist activation of the delta2-opioid receptor subtype in the PAG.
Rodríguez-Díaz
M
M
Neurofarmacología, Instituto Cajal, C.S.I.C., Madrid, Spain.
Garzón
J
J
Sánchez-Blázquez
P
P
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D020881:Enkephalin, D-Penicillamine (2,5)-; D004745:Enkephalins / Q000494:pharmacology*; D019204:GTP-Binding Proteins / Q000502:physiology; D007294:Inositol / Q000378:metabolism; D008297:Male; D051379:Mice; D009842:Oligopeptides / Q000494:pharmacology*; D010487:Periaqueductal Gray / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D037342:Pertussis Toxin; D010716:Phosphatidylinositols / Q000096:biosynthesis*; D017465:Receptors, Opioid, delta / Q000819:agonists* / Q000145:classification* / Q000502:physiology; D012680:Sensitivity and Specificity; D014316:Tritium; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D000700:Analgesics; D004745:Enkephalins; D009842:Oligopeptides; D010716:Phosphatidylinositols; D017465:Receptors, Opioid, delta; D010566:Virulence Factors, Bordetella; D014316:Tritium; C060209:deltorphin II, Ala(2)-; D007294:Inositol; D020881:Enkephalin, D-Penicillamine (2,5)-; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins